Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) just issued a joint statement outlining 10 “Guiding Principles” ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
The Brighterside of News on MSN
Scientists map a road to fairer, more inclusive drug development
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...
Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...
The inflation-adjusted cost of developing a new drug now doubles roughly every nine years. To reverse this trend, the ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...
The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results